Agreement signedPublished 13 May 2024

SRAX, Inc. /
DNA Holdings Venture, Inc.

SRAX to Combine with Web3 Investment Company DNA Holdings Venture, Inc.

Buy side: SRAX, Inc.
Buy sideSRAX, Inc.
Target: DNA Holdings Venture, Inc.
TargetDNA Holdings Venture, Inc.
Source · 13 May 2024Source-verified
Buy side: SRAX, Inc.
Buy sideSRAX, Inc.
Target: DNA Holdings Venture, Inc.
TargetDNA Holdings Venture, Inc.
01 / BuyerSRAX, Inc.
02 / TargetDNA Holdings Venture, Inc.
Source-verified
01

What happened

SRAX, Inc. entered into a merger agreement with DNA Holdings Venture, Inc. DNA will become a wholly-owned subsidiary of SRAX if the transaction closes.

DNA provides advisory services and invests in Web3 infrastructure. As consideration, SRAX will issue DNA shareholders 1,000 shares of Series C Convertible Preferred Stock, convertible into approximately 75.5% of SRAX’s outstanding common stock upon closing.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

SRAX to Combine with Web3 Investment Company DNA Holdings Venture, Inc.

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.